Tradestie Institutional Equity Comparison Engine

CING vs PRLD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CING Overall Edge

CING Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cingulate Inc. Common Stock (CING) driven by superior Growth & Margin, Options & Structure while PRLD counters with relative strength in Momentum & Technical. Fundamentally, CING trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PRLD at N/M Forward P/E and -294.8% operating margin (+41.0% YoY). In options structure, CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against PRLD sits in BREAKDOWN (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CING N/M vs PRLD N/M Fwd P/E
Growth & Margin Winner CING
Op Margin 0.0% vs -294.8% ยท YoY +0.0% vs +41.0%
Momentum & Technical Winner PRLD
1Y +36.4% vs +117.1% ยท 52W Pos 18% vs 36%
Options & Structure Winner CING
BREAKDOWN (16th %ile IV) vs BREAKDOWN (43rd %ile IV)
CING NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.76
+26.93% 1D
Market Cap $62.5M
1M Return +9.17%
1Y Return +36.39%
Forward P/E N/M
Unified AI Score
44.8 / 100 HOLD
Tech 31.0 Fund 50.0 Flow 67.0 Mom 60.0
PRLD NASDAQ
Prelude Therapeutics Incorporated
Pharmaceutical Preparations
$3.30
-3.23% 1D
Market Cap $275.3M
1M Return -2.65%
1Y Return +117.11%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 34.0 Fund 55.0 Flow 67.0 Mom 74.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CING +36.39% PRLD +117.11% Spread: +80.72 pp (PRLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CING TTM Op. Margin: 0.0% PRLD TTM Op. Margin: -294.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CING vs PRLD. Trailing 12-month operating profitability (CING 0.0% vs PRLD -294.8%) and valuation multiples (CING N/M vs PRLD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CING (2) vs PRLD (6)
Institutional Metric CING PRLD Criterion Row Winner
Market Capitalization Scale $62.5M $275.3M Larger Scale PRLD
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +41.0% Higher Growth PRLD
Operating Margin (TTM) Profitability 0.0% -294.8% Higher Margin CING
Net Profit Margin Profitability 0.0% -269.8% Higher Margin CING
Return on Equity (ROE) Capital Efficiency -198.7% -57.7% Higher ROE PRLD
52-Week Range Position Momentum 18% ($3โ€“$12) 36% ($1โ€“$7) Stronger Trend PRLD
Beta / 30D Volatility Risk Regime 1.13ฮฒ ยท 117% Vol 2.01ฮฒ ยท 73% Vol Lower Realized Risk PRLD
Unified Institutional Score Composite Signal 44.8 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite PRLD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CING vs PRLD Buy Guide
CING BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live CING Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PRLD BREAKDOWN
150d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PRLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CING nor PRLD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.